Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
About this item
Full title
Author / Creator
Maeda, Takahiro , Kanzaki, Hiroaki , Chiba, Tetsuhiro , Ao, Junjie , Kanayama, Kengo , Maruta, Susumu , Kusakabe, Yuko , Saito, Tomoko , Kobayashi, Kazufumi , Kiyono, Soichiro , Nakamura, Masato , Ogasawara, Sadahisa , Suzuki, Eiichiro , Ooka, Yoshihiko , Nakamoto, Shingo , Nakagawa, Ryo , Muroyama, Ryosuke , Kanda, Tatsuo , Maruyama, Hitoshi and Kato, Naoya
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Abnormal autocrine fibroblast growth factor 19 (FGF19) production has been observed in several types of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the potential of serum FGF19 as a novel tumor marker of HCC based on a sandwich enzyme-linked immunosorbent assay (ELISA).
The serum FGF19 levels of 304 patients...
Alternative Titles
Full title
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
Authors, Artists and Contributors
Author / Creator
Kanzaki, Hiroaki
Chiba, Tetsuhiro
Ao, Junjie
Kanayama, Kengo
Maruta, Susumu
Kusakabe, Yuko
Saito, Tomoko
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Ogasawara, Sadahisa
Suzuki, Eiichiro
Ooka, Yoshihiko
Nakamoto, Shingo
Nakagawa, Ryo
Muroyama, Ryosuke
Kanda, Tatsuo
Maruyama, Hitoshi
Kato, Naoya
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a3790a15b5894766871e081ea6a088f0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a3790a15b5894766871e081ea6a088f0
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-019-6322-9
